News
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s work, current ...
The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
In recalls, best-by or use-by dates are commonly provided. Even if the affected date has passed, be sure to check your ...
(Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results